Busulfan
Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, Otsuka America Pharmaceutical, Inc.) is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate.
Clinical data | |
---|---|
Trade names | Myleran, Busilvex, Busulfex IV |
Other names | 1,4-butanediol dimethanesulfonate |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682248 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth, intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 60–80% (oral) |
Protein binding | 32.4% |
Metabolism | Liver |
Elimination half-life | 2.5 hours |
Excretion | Urine (25–60%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.228 |
Chemical and physical data | |
Formula | C6H14O6S2 |
Molar mass | 246.29 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
| |
(verify) |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.